Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.08 | N/A |
| PEG Ratio (TTM) | 83.67 | N/A |
| P/S Ratio (TTM) | 3.04 | N/A |
| P/B Ratio (TTM) | 4.64 | N/A |
| P/FCF Ratio (TTM) | 29.44 | N/A |
| Price to 5YR AVG Earnings Ratio | 42.40 | N/A |
| Price to 5YR AVG FCF Ratio | 34.92 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.54% | N/A |
| ROE (TTM) | 16.85% | N/A |
| Net Profit Margin (TTM) | 11.22% | N/A |
| ROIC 5YR AVG | 9.63% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.96% | -12.61% | 12.26% |
| Revenue | 2.43% | -5.95% | 3.70% |
| Net Income | 0.88% | -12.77% | 11.51% |
| Cash Flow | 22.14% | -11.97% | 13.15% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.89 | N/A |
| Quick Ratio (TTM) | 1.23 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 8.63 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 4.13 | N/A |
| LTL to 5YR AVG FCF | 0.08 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.60% | N/A |